Marilyn Howard is a 12 year breast cancer survivor, and she gives all the credit to her faith and God. After talking with her recently, I believe it was God and her own strength that got her through a double mastectomy and stem cell transplant.
A University of Nebraska Medical Center professor will soon begin work on a new embryonic stem cell line approved under President Barack Obama’s less restrictive research guidelines, university officials announced Friday. Dr. Angie Rizzino, who works …
It is amazing that there is now a partnership between the University Of Maryland School Of Medicine and the Vatican with respect for stem cell research. There is a $2.7 million donation that has been given to the University for stem cell research …
A year after President Obama lifted federal restrictions, University of Nebraska Medical Center scientists are moving ahead with research on a newly obtained embryonic stem cell line. The new line, they say, will strengthen research on cancer, stroke …
The NU Medical Center announced Friday that scientists are moving ahead with research on a newly obtained embryonic stem cell line.
A University of Nebraska Medical Center researcher has obtainedone of the first new human embryonic stem cell lines approved foruse since President Obama lifted a ban on federal funding for stemcell research in March 2009.
A University of Nebraska Medical Center professor has obtained an embryonic stem cell line approved under President Barack Obama’s less restrictive research guidelines. UNMC announced Friday that Angie Rizzino will soon begin using the new line. His …
Neuralstem, Inc. announced that its stem cell treatment for ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig’s disease), currently in a FDA-approved Phase I clinical trial, was featured on CNN last night with Dr. Sanjay Gupta, in the piece entitled “Stem Cell Medical Breakthrough”.
CORALVILLE, Iowa — Vivakor, Inc. announced today that its management increased the revenue outlook for its VivaThermic division. Increased global demand for disposable products used to support the stem cell research and therapy markets is following aggressive private and public funding of these markets.
CORALVILLE, Iowa, April 30, 2010 (GLOBE NEWSWIRE) — Vivakor, Inc. (OTCBB:VIVK) announced today that its management increased the revenue outlook for its VivaThermic division. Increased global demand for disposable products used to support the stem …